-
221
4-Aminoquinoline as a privileged scaffold for the design of leishmanicidal agents: structure–property relationships and key biological targets
Published 2025-01-01“…With that information, we seek to give useful guidelines for interested researchers to face the drug discovery and development process for selective and potent leishmanicidal agents based on 4-aminoquinolines.…”
Get full text
Article -
222
Matched pairs demonstrate robustness against inter-assay variability
Published 2025-01-01Get full text
Article -
223
Combination of Enrichment Using Gene Ontology and Transcriptomic Analysis Revealed Contribution of Interferon Signaling to Severity of COVID-19
Published 2022-01-01“…These proteins can be a potential target either as biomarkers or targets in drug discovery. Therefore, we combined enrichment analysis of these proteins to identify biological knowledge related to hyperinflammation. …”
Get full text
Article -
224
RATIONAL DRUG DESIGN OF POTENT V600E-BRAF KINASE INHIBITORS THROUGH MOLECULAR DOCKING SIMULATION
Published 2019-12-01“…Thus; this study provides a valuable approach and new direction to novel drug discovery. There is hope in the future studies to include the synthesis and evaluation of these newly designed inhibitors which can establish them to be the most potent V600E-BRAF inhibitors and efficient ant-melanoma cancer drug. …”
Get full text
Article -
225
DVGEDR: a drug repositioning method based on dual-view fusion and graph enhancement mechanism in heterogeneous networks
Published 2024-12-01“…Abstract Drug repositioning, the discovery of new therapeutic uses for existing drugs, is increasingly gaining attention as a cost-effective and high-yield drug discovery strategy. Existing methods integrate diverse biological information into heterogeneous networks, providing a comprehensive framework for understanding complex drug–disease associations, which also will introduces noise into the data and affect the performance of the model. …”
Get full text
Article -
226
Update on Remdesivir in the Treatment of Novel Coronavirus Pneumonia
Published 2023-08-01“…The total confirmed COVID-19 cases globally as of now topped 620 million, while the total number of fatalities exceeded 6.6 million. The screening, drug discovery, and clinical development of novel treatments are still the hottest subjects in the treatment of COVID-19, and scientists throughout the world are dedicated to identifying prospective therapeutic agents to treat COVID-19 patients, including the new uses of old medications. …”
Get full text
Article -
227
Design and fabrication of novel microfluidic-based droplets for drug screening on a chronic myeloid leukemia cell line.
Published 2025-01-01“…This approach is promising for drug discovery and treatment optimization, as it increases sensitivity and streamlines the screening process.…”
Get full text
Article -
228
Resistin Activates p65 Pathway and Reduces Glycogen Content through Keratin 8
Published 2020-01-01Get full text
Article -
229
Metabolic stability and its role in the discovery of new chemical entities
Published 2019-09-01“…Determination of metabolic profiles of new chemical entities is a key step in the process of drug discovery, since it influences pharmacokinetic characteristics of therapeutic compounds. …”
Get full text
Article -
230
Understanding integrative approach of translational bioinformatics on cardiovascular disease: Myocardial Ischemia
Published 2024-12-01“…The study highlights the impact of personalized medicine, drug discovery, and repurposing through bioinformatics. …”
Get full text
Article -
231
Synthesis and Experimental Validation of New Designed Heterocyclic Compounds with Antiproliferative Activity versus Breast Cancer Cell Lines MCF-7 and MDA-MB-231
Published 2017-01-01“…Recent drug discovery efforts are highly focused towards identification, design, and synthesis of small molecules as anticancer agents. …”
Get full text
Article -
232
-
233
-
234
Repurposing of Drugs for Antibacterial Activities on Selected ESKAPE Bacteria Staphylococcus aureus and Pseudomonas aeruginosa
Published 2020-01-01“…Repurposing of old drugs for the treatment of antimicrobial resistant pathogens has been explored as an alternative strategy in the field of antimicrobial drug discovery. Ten non-antimicrobial compounds were screened for antibacterial activity on two ESKAPE organisms, Staphylococcus aureus and Pseudomonas aeruginosa. …”
Get full text
Article -
235
Exploring target selectivity in designing and identifying PI3Kα inhibitors for triple negative breast cancer with fragment-based and bioisosteric replacement approach
Published 2025-01-01“…After extensive literature analysis, it was observed that fragment-based drug discovery, combined with structure-based virtual screening and bioisosteric replacement strategy, could provide a novel way for hit-to-lead optimization. …”
Get full text
Article -
236
Pharmacophore-based approach for the identification of prospective UDP-2,3-diacylglucosamine hydrolase (LpxH) inhibitor from natural product database against Salmonella Typhi
Published 2025-06-01“…This study illustrates how computational techniques, such as MD simulations and pharmacophore modeling, can speed up drug discovery, especially in the fight against antibiotic resistance.…”
Get full text
Article -
237
High-Yield Generation of Glucose-Responsive Pseudoislets From Murine Insulinoma Cells for Studies and Longitudinal Monitoring of Graft Survival
Published 2025-01-01“…Overall, this platform provides an accessible protocol for generating high yields of 3D pseudoislets and non-invasive longitudinal monitoring of graft survival in different models offer advantages over primary islets for optimization and mechanistic studies of β cell biology, drug discovery, T1D pathogenesis and prevention, and β cell transplantation.…”
Get full text
Article -
238
-
239
Transforming precision medicine: The potential of the clinical artificial intelligent single‐cell framework
Published 2025-01-01“…Future applications of caiSC could include digital cell twins, offering in‐depth simulations of cellular behavior to support drug discovery and personalized treatments. Regulatory considerations are discussed, underscoring the need for SaMD/AIaMD certifications for clinical use. …”
Get full text
Article -
240